Oxygen is vital for cellular metabolism, and when levels in the body fall below normal, it can trigger organ dysfunction and life-threatening complications. Conditions such as COPD, pulmonary fibrosis, pneumonia, and heart failure often reduce oxygen delivery, necessitating supplemental support. Patients may require oxygen intermittently during exertion or continuously if baseline saturation remains low. The method of delivery—nasal cannula, mask, or high-flow system—is chosen based on severity and individual tolerance. Assessment with pulse oximetry and arterial blood gases ensures that oxygen supplementation meets physiologic demands without causing adverse effects.
Beyond immediate symptom relief, oxygen therapy forms part of a broader care plan designed to improve survival, activity tolerance, and quality of life. It helps reduce pulmonary hypertension, lowers risk of hospitalization, and allows individuals to engage more fully in daily activities. Education on safe use, equipment maintenance, and adherence is essential for both patients and caregivers. Integration with pulmonary rehabilitation and lifestyle changes, such as exercise training and smoking cessation, further enhances benefits. Ongoing innovations, including portable concentrators and wearable monitoring devices, are improving convenience and safety. When tailored appropriately, oxygen therapy becomes a transformative intervention that not only sustains life but also restores independence and long-term well-being.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation